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Congenital diaphragmatic hernia (CDH) has an incidence of 1 in 3,000 births and a high mortality rate (33%–
58%). Multifactorial inheritance, teratogenic agents, and genetic abnormalities have all been suggested as possible
etiologic factors. To define candidate regions for CDH, we analyzed cytogenetic data collected on 200 CDH cases,
of which 7% and 5% showed numerical and structural abnormalities, respectively. This study focused on the most
frequent structural anomaly found: a deletion on chromosome 15q. We analyzed material from three of our patients
and from four previously published patients with CDH and a 15q deletion. By using array-based comparative
genomic hybridization and fluorescent in situ hybridization to determine the boundaries of the deletions and by
including data from two individuals with terminal 15q deletions but without CDH, we were able to exclude a
substantial portion of the telomeric region from the genetic etiology of this disorder. Moreover, one patient with
CDH harbored a small interstitial deletion. Together, these findings allowed us to define a minimal deletion region
of ∼5 Mb at chromosome 15q26.1-26.2. The region contains four known genes, of which two—NR2F2 and
CHD2—are particularly intriguing gene candidates for CDH.
Congenital diaphragmatic hernia (CDH [MIM 142340]),
a severe, life-threatening, congenital anomaly character-
ized by variable defect in the diaphragm, pulmonary
hypoplasia, and postnatal pulmonary hypertension, is a
relatively common anomaly (Torfs et al. 1992; Beresford
and Shaw 2000). CDH can occur as an isolated defect,
in combination with multiple congenital anomalies, or
as part of a defined syndrome (Fryns et al. 1979; Enns
et al. 1998). Little is known about the etiology of CDH.
However, there is increasing evidence for a genetic cause
of CDH. Various chromosomal anomalies have been de-
scribed in CDH, with numerical abnormalities (such as
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trisomies 13, 18, and 21) as the most common type.
Structural chromosomal anomalies, involving almost ev-
ery chromosome, have been reported (Lurie 2003). Since
1988, clinical data from all Erasmus Medical Centre
patients with CDH have been stored in a database. Cy-
togenetic data from 200 patients with CDH were avail-
able, and 24 patients (12%) showed an abnormality.
Fourteen patients (7%) showed a numerical abnormality
(trisomy 18 or 21). The remaining 10 patients (5%) had
a structural anomaly, and 3 of those patients (1.5%)
were shown to have a deletion of part of chromosome
15q. The present study focuses on this subset of patients
with CDH and chromosome 15q deletions. Data from
four previously published patients with CDH and small
chromosome 15q deletions were generously made avail-
able to us (table 1) (de Jong et al. 1989; Rosenberg et
al. 1992; Chen et al. 1998; Schlembach et al. 2001).
Clinical evaluation of the seven patients revealed a left-
sided diaphragmatic hernia of the Bochdalek type, in-
878 Am. J. Hum. Genet. 76:877–882, 2005
Table 1
Summary of Clinical and Cytogenetic Data for Patients with Deletions Involving Chromosome 15
Patient Karyotype CDHa Other Abnormalitiesb
Deletion Size
(Mb)
1 46,XY,t(1;14),inv(6),del(15)(q26) Yes Genital anomalies; IUGR 6.3
2 46,XY,r(15)(p11q26) Yes Dysmorphic features; cardiac, renal, genital, and limb
abnormalities; IUGR
19.9
3 46,XY,r(15)(p11q26) Yes Dysmorphic features; cardiac abnormalities; IUGR 23.3
4 46,XX,der(15)t(3;15)(q29;q26.1) Yes Dysmorphic features; cardiac and limb abnormalities; two-
vessel umbilical cord; IUGR
22.8
5 46,XY,r(15)(p11q26.1) Yes Dysmorphic features; genital and limb abnormalities; IUGR 23
6 46,XX,der(15)t(8;15)(q24.1;q26.1) Yes Hydrocephaly; dysmorphic features; cardiac, renal, limb,
and spine abnormalities; IUGR
16.8
7 46,XX,del(15)(q25q26.3) Yes Dysmorphic features; renal and limb abnormalities; IUGR 22.3
8 46,XX,r(15)(p11.1q26.3) No Mental retardation; mild dysmorphic features; IUGR 16.3
9 46,XY,del(15)(q26) No Mental retardation 15.6
NOTE.—Sources for patients 1–3 and 8, Erasmus Medical Centre, Rotterdam, The Netherlands; patient 4, Rosenberg et al. 1992
(case 2); patient 5, de Jong et al. 1989; patient 6, Chen et al. 1998; patient 7, Schlembach et al. 2001; patient 9, J. Wauters, University
Hospital Antwerpen, Antwerpen, Belgium.
a Left-sided, Bochdalek-type CDH (if present).
b IUGR p intrauterine growth retardation (birth weight !3rd percentile).
Figure 1 Array CGH results. a, Patient 1, with CDH and del(15) interstitial deletion. b, Patient 3, with CDH and r(15)(p11q26). c,
Patient 4, with CDH and der(15)t(3;15)(q29;q26.1). d, Patient 7, with CDH and del(15)(q25q26.3). e, Patient 8, without CDH and with
r(15)(p11.1q26.3).
trauterine growth retardation (all patients had birth
weights !3rd percentile), and multiple other congenital
anomalies, such as cardiac and renal abnormalities. In
addition to the seven patients with CDH, we analyzed
data from two patients with mental retardation and
15q deletions but without CDH manifestation. Genomic
DNA was extracted from cultured cells (from patients
1, 2, 3, 4, and 9) or paraffin-embedded tissue (from
patients 5 and 6).
To delineate the possible candidate region, array-
based comparative genomic hybridization (array CGH)
was performed using the 1-Mb Human BAC Array
(Spectral Genomics) in accordance with the manufac-
turer’s instructions. A dye-swap experimental strategy
was used as an additional internal control. Fluorescent
signals on the arrays were visualized using the ScanArray
Express HT scanner. Images were analyzed with Spectral
Ware 2 (Spectral Genomics). Results for patients 1, 3,
4, 7, and 8 are shown in figure 1.
To further delineate the deleted region and to deter-
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Figure 2 FISH results. a, Patient 1: partial metaphase, probe D15Z4 (red signal) at chromosome 15 centromeric locus and probe RP11-
114I24 (green signal) at 15q26.3. b, Patient 2: interphase, probe RP11-369K8 (red signal) and RP11-253B9 (green signal) near the chromosome
5 centromeric region at 5p13.2. c, Patient 3: partial metaphase and interphase, deletion probe RP11-143C19 (green signal) and normal probe
RP11-64K10 (red signal) at 15q23. d, Patient 4: metaphase spread, gain of chromosome 3q29; probe RP1-196F4 (red signal) (3qtel) present
on der(15) and normal signal probe D15Z4 (yellow/red signal) at the centromeric region of chromosome 15. The der(15) contains both signals.
e, Patient 4: partial metaphase, deletion probe RP11-183E24 (green signal) at 15q26.2 and normal probe D15Z4 (yellow/red signal). f, Patient
6: interphase, deletion probe RP11–57P19 (red signal) and normal probe D15Z4 (green signal). Patients 1–6 all have CDH.
mine the deletions in patients 4, 5, and 9, ∼110 BAC
clones were selected from the University of California
Santa Cruz (UCSC) and Ensembl genome browsers to
cover the distal part of chromosome 15. Using the ap-
propriate BAC clones, we performed FISH on metaphase
chromosomes from patients 1, 3, and 4 (fig. 2a and 2c–
2e). Interphase FISH was performed on nuclei extracted
from paraffin-embedded tissues from patients 2, 5, and
6 (fig. 2b and 2f; data for patient 5 not shown). Only
genomic DNA was available from patients 7 and 8, so
the size of the deletion in these patients was determined
using only array CGH. FISH slides were analyzed using
the Axioplan 2 Imaging microscope (Zeiss), and images
were collected using the Isis Software System (Metasys-
tems). Combining FISH and array CGH data, we were
able to approximately determine the breakpoints in all
patients (fig. 3). In patient 1, the interstitial deletion
found by array CGH was confirmed and was narrowed
to a 6-Mb deletion between BAC clones RP11-79A7 and
RP11-616M17. In patient 2, the deletion extended from
a region distal to RP11-79A7; in patient 3, it extended
from a region distal to RP11-300G22. The proximal
breakpoint in patient 4 lies within BAC clone RP11-
617F23. In patient 5, the break occurs distal to RP11-
300G22. In patient 6, the most distal probe tested that
was present on the deleted chromosome 15 was RP11-
79A7. The terminal deletion in patient 7 occurs distal
to RP11-360F18. The proximal breakpoints of the de-
letion interval in the two patients without CDH were
similarly determined (fig. 3). In the first patient without
CDH, who had a ring chromosome 15, the most distal
BAC clone tested that was present on the ring chro-
mosome was RP11-120N1. In the second patient with-
out CDH, the most distal BAC clone present was RP11-
262P8. Combining all data, we determined the smallest
common deletion interval in patients with CDH to be
at 15q26.1-26.2 (which we have termed the “CDH re-
gion”). This region is ∼5 Mb in size and is bordered by
BAC clones RP11-79A7 and RP11-80F4.
CDH is unlike many genetic disorders, for which can-
didate genes can be determined by using linkage analyses
of familial cases, because the vast majority of CDH cases
occur de novo. For this type of disorder, the best way
to determine which genes are involved is by analyzing
a large number of patients for common aberrations by
use of different high-resolution genetic methodologies,
such as FISH or array CGH. This strategy has already
been used successfully to identify genes involved in
CHARGE syndrome (MIM 214800) (Vissers et al. 2004)
and Cornelia de Lange syndrome (CdLS [MIM 122470])
(Krantz et al. 2004; Tonkin et al. 2004).
Isolated reports of distal chromosome 15 deletions
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Figure 3 Schematic representation of the critical CDH region, with partial ideogram of chromosome 15q. Patients (Pt) 1–7 have CDH;
patients 8 and 9 do not have CDH. BAC clones that were tested by array CGH and FISH are listed. The black dots inside boxes indicate that
probes have been tested only on the array and not by FISH. The smallest common overlapping deletion interval involved in CDH is denoted
by the large red square.
in patients with CDH have been described elsewhere
(reviewed by Hengstschlager et al. [2004] and Schlem-
bach et al. [2001]), suggesting involvement of this region
in the pathogenesis of CDH. In the past year, three new
cases of CDH have been reported (Biggio et al. 2004;
Hengstschlager et al. 2004; Tonks et al. 2004). However,
detailed molecular cytogenetic analyses of these cases are
currently unavailable. To find other possible cases to
study, we performed systematic FISH analysis on data
from 25 patients with CDH, with the use of BAC clones
spanning the CDH region. We identified no additional
15q deletions.
With array CGH and systematic FISH analysis per-
formed on the seven patients with CDH and 15q dele-
tions and the two patients without CDH but with 15q
deletions, our study is the first to analyze data from
multiple patients with CDH in detail and to refine the
chromosome 15q critical CDH region to an ∼5-Mb area
within 15q26.1-26.2. In all patients, clinical abnormal-
ities resembled the features described for other patients
with a 15q deletion or with related syndromes, such as
Fryns syndrome (MIM 229850) (Fryns et al. 1979). As
can be expected, the r(15) patients, with or without CDH,
had phenotypes similar to those seen with ring chromo-
some 15 syndrome (Butler et al. 1988; Rogan et al. 1996).
To our knowledge, CDH has not yet been described as a
main feature in ring chromosome 15 syndrome.
In our study, there appears to be a relationship be-
tween the number of abnormalities present and the size
of the deletion. For example, the first patient, who had
the smallest deletion, has few additional congenital de-
fects. All other patients have deletions that are similar
in size and have a similar spectrum of anatomical anom-
alies. In the two patients with an unbalanced translo-
cation, the variation in phenotype could also be due, in
part, to the presence of extra material from another
chromosome.
The region of the smallest common deletion contains
four known genes, none of which have been previously
shown to be involved in diaphragm development or dia-
phragmatic hernia. On the basis of their structure and
function, two of these genes are very interesting with
respect to a potential relationship with CDH. The first
gene, NR2F2 (MIM 107773; also known as “COUP-
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TFII”), is a member of the steroid/thyroid hormone re-
ceptor subfamily and is involved in retinoic acid metab-
olism (Kimura et al. 2002). A knockout mouse model
of NR2F2 showed that Nr2f2/ mice are not viable and
die at E9 in utero because of arrest of cardiac devel-
opment (Pereira et al. 1999). Heterozygous knockout
mice have poor viability in the neonatal period and are
smaller than wild-type mice. However, the exact cause
of death in these mice is not clear. The second interesting
gene is the chromodomain helicase 2 gene (CHD2 [MIM
602119]), a member of the SNF2/RAD54 helicase gene
family. Recently, mutations in another member of this
family (CHD7) have been found to cause CHARGE syn-
drome (Vissers et al. 2004). The third gene in the CDH
region is the repulsive guidance molecule gene, RGMA
(MIM 607362), which is involved in the guidance of
growth cones in developing neurons (Brinks et al. 2004).
This gene is not known to play a role in diaphragm
development, nor has it been described in muscle or
lung development. The fourth gene located in the small-
est region of overlap is the sialyltransferase 8B gene
(SIAT8B [MIM 602546]), which plays a role in the
adhesive properties of neural cell adhesion molecules
(Angata et al. 1997).
Haploinsufficiency due to the loss of a copy of one of
these genes may be enough to result in a diaphragmatic
defect. At the present time, the precise mechanism by
which a deletion of or within one of these genes or a
related gene mutation causes this developmental defect
can only be speculated.
Elsewhere, other genes on chromosome 15q have been
suggested as being involved in the pathogenesis of dia-
phragmatic defects. Biggio et al. (2004) suggested that
the myocyte enhancer factor 2A gene, MEF2A (MIM
600660), could be involved in the pathogenesis of dia-
phragmatic defects. MEF2A maps to 15q26.3 and is
involved in the differentiation of muscle cells from their
precursors. Some genes involved in vitamin A metabo-
lism—for example, RALDH2 (MIM 603687), which
maps to 15q21—have also been implicated in the path-
ogenesis of CDH (Greer et al. 2003). Both MEF2A and
RALDH2 are located outside our candidate critical
CDH region, which limits their possible role in CDH in
our subgroup of patients.
In conclusion, we have mapped a potential critical
CDH region to 5 Mb at chromosome 15q26.1-26.2, a
region that contains four genes, of which two are es-
pecially intriguing candidates in the etiology of dia-
phragmatic defects. Further research is needed to con-
firm their exact role in CDH and to determine the
pathogenic mechanism. As a first step, we are performing
FISH and mutation analyses of a large group of patients
with CDH who have normal karyotypes. In the future,
prenatal screening for 15q abnormalities when a dia-
phragmatic hernia is detected could give better clues for
predicting the outcome and could provide more infor-
mation for genetic counseling.
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